- Home
- PEGA vs CORT Comparison
PEGA vs CORT Comparison
Compare PEGA & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEGA
- CORT
- Stock Information
- Founded
- PEGA 1983
- CORT 1998
- Country
- PEGA United States
- CORT United States
- Employees
- PEGA N/A
- CORT N/A
- Industry
- PEGA EDP Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- PEGA Technology
- CORT Health Care
- Exchange
- PEGA Nasdaq
- CORT Nasdaq
- Market Cap
- PEGA 9.2B
- CORT 7.6B
- IPO Year
- PEGA 1996
- CORT N/A
- Fundamental
- Price
- PEGA $58.07
- CORT $72.87
- Analyst Decision
- PEGA Buy
- CORT Strong Buy
- Analyst Count
- PEGA 11
- CORT 4
- Target Price
- PEGA $60.45
- CORT $139.00
- AVG Volume (30 Days)
- PEGA 1.1M
- CORT 634.6K
- Earning Date
- PEGA 10-22-2025
- CORT 10-29-2025
- Dividend Yield
- PEGA 0.10%
- CORT N/A
- EPS Growth
- PEGA 61.54
- CORT N/A
- EPS
- PEGA 1.18
- CORT 1.11
- Revenue
- PEGA $1,676,025,000.00
- CORT $716,080,000.00
- Revenue This Year
- PEGA $16.35
- CORT $30.62
- Revenue Next Year
- PEGA $6.37
- CORT $37.68
- P/E Ratio
- PEGA $49.36
- CORT $65.48
- Revenue Growth
- PEGA 12.47
- CORT 25.71
- 52 Week Low
- PEGA $29.84
- CORT $35.45
- 52 Week High
- PEGA $60.96
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- PEGA 64.08
- CORT 56.90
- Support Level
- PEGA $55.84
- CORT $67.32
- Resistance Level
- PEGA $57.93
- CORT $72.52
- Average True Range (ATR)
- PEGA 1.35
- CORT 2.19
- MACD
- PEGA 0.55
- CORT 0.36
- Stochastic Oscillator
- PEGA 88.31
- CORT 74.30
About PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.